Certify Raises $40M To Advance Healthcare Provider Data Infrastructure
Certify's $40 million round was led by Transformation Capital, and included support from General Catalyst, Upfront Ventures and SemperVirens.
Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in Funding
Vor Bio is licensing global rights a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last month ceased its cancer R&D and announced it would explore strategic alternatives.
From Burnout to Breakthrough: Reinventing Pediatric Care for the Next Generation
There is no singular cause to pediatrician burnout. Rather, it’s a web of interconnected issues, compounded and feeding upon each other. And if we want to truly support pediatricians and the children they care for, we need to stop treating symptoms and start untangling the root causes.
Beyond Technology: Aligning AI Tools with Systemic Change in Healthcare
The widespread investment in AI furthers economists’ optimism about a “roaring 20’s” of worker productivity on the horizon. However, this will not take place in health care without accompanying systemic and organizational actions that rethink what we financially incentivize, how we integrate new technologies, how we shift tasks, and how we prepare the workforce.
What VCs Have Learned About Health Tech in the Public Markets
Two digital health companies have gone public this year: Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech in the public markets.